Amporin Pharmaceuticals

Switzerland
Breíl, Grisons, Switzerland, 4054

Company profile

Amporin Pharmaceuticals company profile

Amporin Pharmaceuticals seeks to create a new class of small-molecule medications that block and eradicate harmful soluble oligomers and holes found within cell membranes.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2024-01-01, Year

Headquarters

Postal code
4054
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $170,313 / 2024-07-25
Investors
1
Lead investors
1
Articles
3

Founders and investors

Lead investors

Venture Kick

Investors

Venture Kick